RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2021

Feb 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2021-02-11

Reporting Person: Meeker David P (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-11	Stock Option (right to buy)	$30.66	A	220000	Acquired	2031-02-10	Common Stock (220000)	Direct

Footnotes

F1: The stock options were granted on February 11, 2021. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.